157 related articles for article (PubMed ID: 37695304)
1. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces
Nguyen HT; Venter H; Woolford L; Young KA; McCluskey A; Garg S; Sapula SS; Page SW; Ogunniyi AD; Trott DJ
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0042423. PubMed ID: 37695304
[TBL] [Abstract][Full Text] [Related]
2.
Pi H; Nguyen HT; Venter H; Boileau AR; Woolford L; Garg S; Page SW; Russell CC; Baker JR; McCluskey A; O'Donovan LA; Trott DJ; Ogunniyi AD
Front Microbiol; 2020; 11():1556. PubMed ID: 32849325
[TBL] [Abstract][Full Text] [Related]
3. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens.
Nguyen HT; Venter H; Veltman T; Williams R; O'Donovan LA; Russell CC; McCluskey A; Page SW; Ogunniyi AD; Trott DJ
Int J Antimicrob Agents; 2021 May; 57(5):106323. PubMed ID: 33746046
[TBL] [Abstract][Full Text] [Related]
4. Impact of a Novel Anticoccidial Analogue on Systemic
Nguyen HT; Venter H; Woolford L; Young K; McCluskey A; Garg S; Page SW; Trott DJ; Ogunniyi AD
Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052942
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.
Ogunniyi AD; Khazandi M; Stevens AJ; Sims SK; Page SW; Garg S; Venter H; Powell A; White K; Petrovski KR; Laven-Law G; Tótoli EG; Salgado HR; Pi H; Coombs GW; Shinabarger DL; Turnidge JD; Paton JC; McCluskey A; Trott DJ
PLoS One; 2017; 12(9):e0183457. PubMed ID: 28873428
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
7. The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis.
Fantin B; Poujade J; Grégoire N; Chau F; Roujansky A; Kieffer N; Berleur M; Couet W; Nordmann P
Clin Microbiol Infect; 2019 Dec; 25(12):1563.e5-1563.e8. PubMed ID: 31494253
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections.
Nguyen HT; Morshed MT; Vuong D; Crombie A; Lacey E; Garg S; Pi H; Woolford L; Venter H; Page SW; Piggott AM; Trott DJ; Ogunniyi AD
Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34208698
[TBL] [Abstract][Full Text] [Related]
9. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
10. Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
Zhou YF; Tao MT; Feng Y; Yang RS; Liao XP; Liu YH; Sun J
J Antimicrob Chemother; 2017 Jun; 72(6):1723-1730. PubMed ID: 28333193
[TBL] [Abstract][Full Text] [Related]
11. Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis.
Le Menestrel A; Guerin F; Chau F; Massias L; Benchetrit L; Cattoir V; Fantin B; de Lastours V
J Antimicrob Chemother; 2021 Dec; 77(1):155-163. PubMed ID: 34718597
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo enhancement effect of glabridin on the antibacterial activity of colistin, against multidrug resistant Escherichia coli strains.
Yang J; Zhang L; He X; Gou X; Zong Z; Luo Y
Phytomedicine; 2024 Jul; 130():155732. PubMed ID: 38776738
[TBL] [Abstract][Full Text] [Related]
13. Effects of colistin on biofilm matrices of Escherichia coli and Staphylococcus aureus.
Klinger-Strobel M; Stein C; Forstner C; Makarewicz O; Pletz MW
Int J Antimicrob Agents; 2017 Apr; 49(4):472-479. PubMed ID: 28267594
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.
Simonetti O; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mazzocato S; Kamysz W; Kamysz E; Provinciali M; Giacometti A; Guerrieri M; Offidani A
Peptides; 2014 May; 55():17-22. PubMed ID: 24531033
[TBL] [Abstract][Full Text] [Related]
15. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics.
MacNair CR; Stokes JM; Carfrae LA; Fiebig-Comyn AA; Coombes BK; Mulvey MR; Brown ED
Nat Commun; 2018 Jan; 9(1):458. PubMed ID: 29386620
[TBL] [Abstract][Full Text] [Related]
16. Fructose-coated Ångstrom silver prevents sepsis by killing bacteria and attenuating bacterial toxin-induced injuries.
Yin H; Zhou M; Chen X; Wan TF; Jin L; Rao SS; Tan YJ; Duan R; Zhang Y; Wang ZX; Wang YY; He ZH; Luo MJ; Hu XK; Wang Y; Situ WY; Tang SY; Liu WE; Chen CY; Xie H
Theranostics; 2021; 11(17):8152-8171. PubMed ID: 34373734
[TBL] [Abstract][Full Text] [Related]
17. Melatonin overcomes MCR-mediated colistin resistance in Gram-negative pathogens.
Liu Y; Jia Y; Yang K; Tong Z; Shi J; Li R; Xiao X; Ren W; Hardeland R; Reiter RJ; Wang Z
Theranostics; 2020; 10(23):10697-10711. PubMed ID: 32929375
[No Abstract] [Full Text] [Related]
18. Synergistic Antimicrobial Activity of Colistin in Combination with Rifampin and Azithromycin against Escherichia coli Producing MCR-1.
Li Y; Lin X; Yao X; Huang Y; Liu W; Ma T; Fang B
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224527
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli.
Wang Y; Li H; Xie X; Wu X; Li X; Zhao Z; Luo S; Wan Z; Liu J; Fu L; Li X
J Glob Antimicrob Resist; 2020 Mar; 20():351-359. PubMed ID: 31557565
[TBL] [Abstract][Full Text] [Related]
20. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
